Literature DB >> 4088431

An ultramicro bioluminescence assay of enolase: application to human cerebrospinal fluid.

J L Viallard, M R Murthy, B Dastugue.   

Abstract

A highly sensitive method based on bioluminescence is described for the assay of enolase which can measure as little as 0.4 X 10(-6) IU of activity. This corresponds to an amount of enzyme present in 1-2 microliters of normal human cerebrospinal fluid and is therefore easily applicable to clinical samples of CSF which can only be obtained in very small amounts. The reproducibility of the method is very high within a broad range of enzyme concentrations and the assay is linear from 0.4 X 10(-6) IU up to at least 50 X 10(-6) IU of enzyme. This would permit application of the method to biological samples containing low as well as high enolase activities and especially for monitoring changes in enolase concentrations in the CSF and in the serum, as a function of pathological lesions in the central nervous system and other tissues.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4088431     DOI: 10.1007/BF00988598

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  13 in total

1.  D-ERYTHRONIC ACID 3-PHOSPHATE. A SUBSTRATE FOR ENOLASE.

Authors:  F WOLD; R BARKER
Journal:  Biochim Biophys Acta       Date:  1964-06-01

2.  Firefly luminescence in the study of energy transfer mechanisms. I. Substrate and enzyme determination.

Authors:  B L STREHLER; J R TOTTER
Journal:  Arch Biochem Biophys       Date:  1952-09       Impact factor: 4.013

3.  Enolase isoenzymes in rat tissues. Electrophoretic, chromatographic, immunological and kinetic properties.

Authors:  C C Rider; C B Taylor
Journal:  Biochim Biophys Acta       Date:  1974-09-13

4.  Highly sensitive immunoassays for three forms of rat brain enolase.

Authors:  K Kato; F Suzuki; Y Umeda
Journal:  J Neurochem       Date:  1981-03       Impact factor: 5.372

5.  Optimized bioluminescence assay of creatine kinase and creatine kinase B-subunit activity.

Authors:  A Lundin; B Jäderlund; T Lövgren
Journal:  Clin Chem       Date:  1982-04       Impact factor: 8.327

6.  Immunoreactive nervous system of specific enolase (14-3-2 protein) in human serum and cerebrospinal fluid.

Authors:  K W Brown; P A Kynoch; R J Thompson
Journal:  Clin Chim Acta       Date:  1980-02-28       Impact factor: 3.786

7.  Editorial: Cerebrospinal fluid: the lymph of brain?

Authors: 
Journal:  Lancet       Date:  1975-09-06       Impact factor: 79.321

8.  Brain endolases as specific markers of neuronal and glial cells.

Authors:  D Schmechel; P J Marangos; A P Zis; M Brightman; F K Goodwin
Journal:  Science       Date:  1978-01-20       Impact factor: 47.728

9.  A bioluminescent assay for enolase (EC 4.2.1.11) activity in human serum and cerebrospinal fluid.

Authors:  R A Wevers; A A Jacobs; O R Hommes
Journal:  Clin Chim Acta       Date:  1983-12-15       Impact factor: 3.786

10.  A more sensitive radioimmunoassay for neuron-specific enolase suitable for cerebrospinal fluid determinations.

Authors:  A M Parma; P J Marangos; F K Goodwin
Journal:  J Neurochem       Date:  1981-03       Impact factor: 5.372

View more
  5 in total

1.  Electrophoretic assessment of aqueous and serum neurone-specific enolase in retinoblastoma and ocular malignant melanoma.

Authors:  B S Shine; J Hungerford; B Vaghela; G A Sheraidah
Journal:  Br J Ophthalmol       Date:  1990-07       Impact factor: 4.638

Review 2.  Point-of-Care-Testing in Acute Stroke Management: An Unmet Need Ripe for Technological Harvest.

Authors:  Dorin Harpaz; Evgeni Eltzov; Raymond C S Seet; Robert S Marks; Alfred I Y Tok
Journal:  Biosensors (Basel)       Date:  2017-08-03

3.  Electrochemical Detecting Lung Cancer-Associated Antigen Based on Graphene-Gold Nanocomposite.

Authors:  Zheng Wei; Junping Zhang; Aihua Zhang; Yanchun Wang; Xiaoping Cai
Journal:  Molecules       Date:  2017-03-02       Impact factor: 4.411

4.  Mice over-expressing the myocardial creatine transporter develop progressive heart failure and show decreased glycolytic capacity.

Authors:  Darci Phillips; Michiel Ten Hove; Jurgen E Schneider; Colin O Wu; Liam Sebag-Montefiore; Angel M Aponte; Craig A Lygate; Julie Wallis; Kieran Clarke; Hugh Watkins; Robert S Balaban; Stefan Neubauer
Journal:  J Mol Cell Cardiol       Date:  2009-11-11       Impact factor: 5.000

5.  Use of Tethered Enzymes as a Platform Technology for Rapid Analyte Detection.

Authors:  Roy Cohen; James P Lata; Yurim Lee; Jean C Cruz Hernández; Nozomi Nishimura; Chris B Schaffer; Chinatsu Mukai; Jacquelyn L Nelson; Sharon A Brangman; Yash Agrawal; Alexander J Travis
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.